RecruitingNot ApplicableNCT05286034

Using Artificial Intelligence-based ChatBot to Improve Women's Participation to Cervical Cancer Screening Programme

Artificial Intelligence-assisted Decision-making to Improve Women's Participation to Cervical Cancer Screening in Occitanie Region-France


Sponsor

International Agency for Research on Cancer

Enrollment

3,000 participants

Start Date

Nov 3, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This project looks to improve the return rate of HPV self-sampling (HPVss) as well as the management of women HPVss positive.


Eligibility

Sex: FEMALEMin Age: 30 YearsMax Age: 65 Years

Inclusion Criteria4

  • aged 30-65
  • did not perform a pap smear in the last 4 years
  • are living in deprived clusters in the Occitanie region.
  • did not answer to a first "invitation" letter to perform a clinician-collected HPV testing

Exclusion Criteria7

  • outside the target age group
  • had a Pap smear in the past 3 years
  • had hysterectomy including cervix
  • are pregnant
  • already scheduled a screening appointment or had just attended a HPV screening
  • had a cervical abnormality that was under exploration and/or treatment.
  • participated to the study pilot

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALDecision aid tailored to women with lower educational attainment,accessible via artificial intelligence-based Chatbot platforms

Non-compliant women those that have not been screened for more than 4 years and living in the disadvantaged areas will be sent screening reminder letters to perform HPV self-sampling (HPVss) test, with access to decision aid tailored to women with lower education attainment and available via Chatbot platforms. ChatBot will deliver information in a responsive, conversational way via text and spoken language in multiple languages through multiple mobile channels.


Locations(1)

Centre Régional de Coordination des Dépistages des Cancers-Centre d'Occitanie

Carcassone, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05286034


Related Trials